MAZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 323
AS - Asia 99
AF - Africa 25
SA - Sud America 2
OC - Oceania 1
Totale 1.008
Nazione #
US - Stati Uniti d'America 544
SE - Svezia 142
IT - Italia 58
BG - Bulgaria 41
CN - Cina 34
SG - Singapore 30
DE - Germania 26
GB - Regno Unito 20
CA - Canada 13
AT - Austria 12
CI - Costa d'Avorio 12
SN - Senegal 12
FR - Francia 11
VN - Vietnam 10
IN - India 8
TR - Turchia 7
UA - Ucraina 6
HK - Hong Kong 5
RU - Federazione Russa 3
SA - Arabia Saudita 3
BE - Belgio 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
HR - Croazia 1
JP - Giappone 1
NG - Nigeria 1
PA - Panama 1
PL - Polonia 1
Totale 1.008
Città #
Fairfield 73
Woodbridge 64
Seattle 55
Chandler 53
Sofia 41
Houston 37
Ashburn 36
Wilmington 29
Serra 24
Cambridge 22
New York 22
London 15
Ottawa 13
Princeton 13
Abidjan 12
Ann Arbor 12
Boardman 12
Dakar 12
Lawrence 12
Singapore 12
Vienna 12
Bremen 11
Beijing 10
Medford 10
Marseille 9
Ogden 9
Dearborn 8
Florence 8
Frankfurt am Main 8
Des Moines 7
Pisa 7
Nanjing 5
Aosta 4
Hong Kong 4
San Diego 4
Dong Ket 3
Jeddah 3
Manchester 3
Munich 3
Brussels 2
Da Nang 2
Hebei 2
Izmir 2
Milan 2
Nanchang 2
Queens 2
Santa Clara 2
Seacroft 2
Tianjin 2
Baotou 1
Chengdu 1
Chicago 1
Harran 1
Hefei 1
Highland 1
Istanbul 1
Jiaxing 1
Kent 1
Kocaeli 1
Lagos 1
Melbourne 1
Ningbo 1
Norwalk 1
Panama City 1
Pordenone 1
Pune 1
Rome 1
San Francisco 1
Santiago 1
Shenyang 1
Vicopisano 1
Warsaw 1
Zagreb 1
Totale 741
Nome #
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 138
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 114
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 111
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 99
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 94
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 86
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 75
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 74
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 66
Retinal, choroidal and optic disc analysis in patients with Graves' disease with or without orbitopathy 64
Rehabilitative orbital decompression for Graves’ orbitopathy: results of a randomized clinical trial 60
Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study 55
Totale 1.036
Categoria #
all - tutte 3.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 0 0 22 12 32 27 19 16 17 10 27 5
2020/202180 7 4 3 16 5 2 4 5 7 6 11 10
2021/2022197 0 3 0 19 50 17 2 6 28 27 4 41
2022/2023260 34 48 25 18 21 22 2 24 53 0 12 1
2023/2024115 2 9 10 1 14 25 5 8 2 2 20 17
2024/202520 3 12 5 0 0 0 0 0 0 0 0 0
Totale 1.036